SKYE
Price
$4.11
Change
-$0.14 (-3.29%)
Updated
Jun 27 closing price
Capitalization
128.62M
VKTX
Price
$26.52
Change
-$1.65 (-5.86%)
Updated
Jun 27 closing price
Capitalization
2.98B
24 days until earnings call
Interact to see
Advertisement

SKYE vs VKTX

Header iconSKYE vs VKTX Comparison
Open Charts SKYE vs VKTXBanner chart's image
Skye Bioscience
Price$4.11
Change-$0.14 (-3.29%)
Volume$7.49M
Capitalization128.62M
Viking Therapeutics
Price$26.52
Change-$1.65 (-5.86%)
Volume$6.32M
Capitalization2.98B
SKYE vs VKTX Comparison Chart in %
Loading...
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SKYE vs. VKTX commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SKYE is a Hold and VKTX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (SKYE: $4.11 vs. VKTX: $26.52)
Brand notoriety: SKYE and VKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SKYE: 811% vs. VKTX: 177%
Market capitalization -- SKYE: $128.62M vs. VKTX: $2.98B
SKYE [@Biotechnology] is valued at $128.62M. VKTX’s [@Biotechnology] market capitalization is $2.98B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SKYE’s FA Score shows that 0 FA rating(s) are green whileVKTX’s FA Score has 0 green FA rating(s).

  • SKYE’s FA Score: 0 green, 5 red.
  • VKTX’s FA Score: 0 green, 5 red.
According to our system of comparison, SKYE is a better buy in the long-term than VKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SKYE’s TA Score shows that 4 TA indicator(s) are bullish while VKTX’s TA Score has 2 bullish TA indicator(s).

  • SKYE’s TA Score: 4 bullish, 3 bearish.
  • VKTX’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, SKYE is a better buy in the short-term than VKTX.

Price Growth

SKYE (@Biotechnology) experienced а +90.28% price change this week, while VKTX (@Biotechnology) price change was +1.96% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

VKTX is expected to report earnings on Jul 23, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VKTX($2.98B) has a higher market cap than SKYE($129M). SKYE YTD gains are higher at: 45.230 vs. VKTX (-34.095). SKYE has higher annual earnings (EBITDA): -31.66M vs. VKTX (-171.93M). VKTX has more cash in the bank: 852M vs. SKYE (59.2M). SKYE has less debt than VKTX: SKYE (412K) vs VKTX (1M). SKYE (0) and VKTX (0) have equivalent revenues.
SKYEVKTXSKYE / VKTX
Capitalization129M2.98B4%
EBITDA-31.66M-171.93M18%
Gain YTD45.230-34.095-133%
P/E Ratio3.57N/A-
Revenue00-
Total Cash59.2M852M7%
Total Debt412K1M41%
FUNDAMENTALS RATINGS
SKYE vs VKTX: Fundamental Ratings
SKYE
VKTX
OUTLOOK RATING
1..100
4064
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
40
Fair valued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
9791
PRICE GROWTH RATING
1..100
3564
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SKYE's Valuation (39) in the null industry is in the same range as VKTX (40) in the Biotechnology industry. This means that SKYE’s stock grew similarly to VKTX’s over the last 12 months.

VKTX's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as SKYE (100) in the null industry. This means that VKTX’s stock grew similarly to SKYE’s over the last 12 months.

VKTX's SMR Rating (91) in the Biotechnology industry is in the same range as SKYE (97) in the null industry. This means that VKTX’s stock grew similarly to SKYE’s over the last 12 months.

SKYE's Price Growth Rating (35) in the null industry is in the same range as VKTX (64) in the Biotechnology industry. This means that SKYE’s stock grew similarly to VKTX’s over the last 12 months.

SKYE's P/E Growth Rating (98) in the null industry is in the same range as VKTX (100) in the Biotechnology industry. This means that SKYE’s stock grew similarly to VKTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SKYEVKTX
RSI
ODDS (%)
Bearish Trend 3 days ago
89%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
88%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
86%
Bearish Trend 3 days ago
87%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
SKYE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VKTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AELTF1.10N/A
N/A
Adacel Technologies Ltd.
FOCIF2.50N/A
N/A
Focusrite Plc.
GSFD0.12N/A
N/A
Global Seafood Technologies, Inc.
HPHTF11.46N/A
N/A
Hamamatsu Photonics
TERRF9.95N/A
N/A
Terna Rete Elettrica Nazionale SPA

SKYE and

Correlation & Price change

A.I.dvisor indicates that over the last year, SKYE has been loosely correlated with CRBP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SKYE jumps, then CRBP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SKYE
1D Price
Change %
SKYE100%
-3.29%
CRBP - SKYE
46%
Loosely correlated
-7.73%
JANX - SKYE
41%
Loosely correlated
-1.57%
OVID - SKYE
36%
Loosely correlated
-11.95%
VKTX - SKYE
34%
Loosely correlated
-5.86%
ARWR - SKYE
33%
Loosely correlated
+0.06%
More

VKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VKTX has been loosely correlated with GPCR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if VKTX jumps, then GPCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VKTX
1D Price
Change %
VKTX100%
-5.86%
GPCR - VKTX
49%
Loosely correlated
N/A
CRNX - VKTX
49%
Loosely correlated
-0.10%
KRYS - VKTX
47%
Loosely correlated
-2.60%
ALT - VKTX
47%
Loosely correlated
-54.60%
ROIV - VKTX
46%
Loosely correlated
-1.81%
More